This interview is part of a series in which experts discuss key aspects of the malaria challenge– innovation, program implementation, finance and policy. We hope the series sparks conversation and encourages others to determine how they can best contribute to the fight to end malaria for good. Follow the conversation on twitter using #GBCtalksmalaria In your opinion, what would be some positive game … Read More
#GBCtalksmalaria with Herbert Schilthuis, Heineken
This interview is part of a series in which experts discuss key aspects of the malaria issue – innovation, program implementation, finance and policy. We hope the series sparks conversation and encourages others to determine how they can best contribute to the fight to end malaria for good. Follow the conversation on twitter using #GBCtalksmalaria In your opinion what would be some positive … Read More
#GBCtalksmalaria with Jon Pender, GSK
This interview is part of a series in which experts discuss key aspects of the malaria challenge– innovation, program implementation, finance and policy. We hope the series sparks conversation and encourages others to determine how they can best contribute to the fight to end malaria for good. Follow the conversation on twitter using #GBCtalksmalaria In your opinion, what would be positive game changers … Read More
#GBCtalksmalaria Interview Series
Tremendous progress has been made in the fight to end malaria. Seventeen countries have reduced malaria cases to the point where it is no longer endemic – and eight of these have fully eliminated malaria. Since 2000, malaria prevention and treatment programs have saved an estimated 4.3 million lives. Companies have helped to both accelerate this progress and shape malaria … Read More
Corporate Leadership in the Fight to End Malaria
Tremendous progress has been made in the fight to end malaria. Seventeen countries have reduced malaria cases to the point where it is no longer endemic – and eight of these have fully eliminated malaria. Since 2000, malaria prevention and treatment programs have saved an estimated 4.3 million lives. Companies have helped to both accelerate this progress and shape malaria … Read More
Healthy People, Healthy Region: Driving Corporate Action to Eliminate Malaria in Asia-Pacific
The Healthy People, Healthy Region: Driving Corporate Action to Eliminate Malaria in Asia-Pacific private sector meeting was held on May 10, 2016 in Bangkok, Thailand as part of the Joint Malaria Week. Co-organized by the Asian Pacific Leaders Malaria Alliance (APLMA) and the Myanmar Health and Development Consortium (MHDC), with support from Sanofi and Sumitomo Chemical, the meeting brought together … Read More
Business Must Continue to Lead to “End Malaria for Good”
End Malaria for Good. That’s the theme of this year’s World Malaria Day – a fitting, aspirational and accomplishable goal as we kick off Agenda 2030 in this transitional year of the Sustainable Development Goals (SDG). Across the global malaria community, we should feel gratified with our tremendous success, having saved over 6.2 million lives that would have been lost … Read More
New Private Sector Partnership Led by GSK Raises £22 million to improve health systems for malaria
GSK and UK-based charity Comic Relief have announced a £22 million partnership providing grant funding to organizations addressing malaria and improving health systems in some of the world’s worst-affected regions. Grant recipients in Ghana, Mozambique, Sierra Leone, Tanzania and the Greater Mekong region will benefit from this collaboration, which will promote research into medicines and vaccines, improve the supply of … Read More
RBM Partnership Approves Reformed Structure
The Roll Back Malaria Partnership Board approved a new Governance Framework at its 29th Board Meeting in Geneva which will refine and refocus the current Partnership to better advocate for and attract increased attention to the global malaria fight for the next fifteen years. Part of this Board approval will see the creation of a high-level Malaria Council, a Partnership … Read More
Statement from the Private Sector Constituency to the Roll Back Malaria Partnership on the Passing of Alan Magill
The Private Sector Constituency of the Roll Back Malaria Partnership Board is deeply saddened by the sudden loss of our colleague and friend Alan Magill. Many of us worked closely with Alan during his time at the Gates Foundation. We all admired his visionary leadership of the Malaria Portfolio as he challenged not only his team but us too in … Read More